{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,8]],"date-time":"2026-02-08T05:40:35Z","timestamp":1770529235668,"version":"3.49.0"},"reference-count":67,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2018,2,8]],"date-time":"2018-02-08T00:00:00Z","timestamp":1518048000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Acta Pharmacol Sin"],"published-print":{"date-parts":[[2018,6]]},"DOI":"10.1038\/aps.2017.191","type":"journal-article","created":{"date-parts":[[2018,2,8]],"date-time":"2018-02-08T11:01:42Z","timestamp":1518087702000},"page":"952-960","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":48,"title":["Different network pharmacology mechanisms of Danshen-based Fangjis in the treatment of stable angina"],"prefix":"10.1038","volume":"39","author":[{"given":"Guo-xia","family":"Zhang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ying-ying","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiao-xu","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Peng-qian","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jun","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Qiong","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhong","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2018,2,8]]},"reference":[{"key":"BFaps2017191_CR1","first-page":"9868694","volume":"2017","author":"FC Li","year":"2017","unstructured":"Li FC, Tian DD . Salvia miltiorrhiza roots against cardiovascular disease: consideration of herb-drug interactions. BioMed Res Int 2017; 2017: 9868694.","journal-title":"BioMed Res Int"},{"key":"BFaps2017191_CR2","unstructured":"Higgins JPT, Green S . Cochrane handbook for systematic reviews of interventions version 5.1.0. The Cochrane Collaboration 2011."},{"key":"BFaps2017191_CR3","first-page":"e1000100","volume":"6","author":"A Liberati","year":"2009","unstructured":"Liberati A, Altman DG, Tetzlaff J, Mulrow C, G\u00f8tzsche P, Ioannidis J, et al. The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate healthcare interventions: explanation and elaboration. BMJ 2009; 6: e1000100.","journal-title":"BMJ"},{"key":"BFaps2017191_CR4","doi-asserted-by":"publisher","first-page":"e1","DOI":"10.1016\/j.jclinepi.2010.03.004","volume":"63","author":"D Moher","year":"2010","unstructured":"Moher D, Hopewell S, Schulz KF, Montori V, G\u00f8tzsche P, Devereaux P, et al. CONSORT 2010 explanation and elaboration: updated guidelines for reporting parallel group randomised trials. J Clin Epidemiol 2010; 63: e1\u201337.","journal-title":"J Clin Epidemiol"},{"key":"BFaps2017191_CR5","unstructured":"Review Manager (RevMan) Program RMRC. Version 5.1. Copenhagen: The Nordic Cochrane Centre, The Cochrane Collaboration 2011."},{"key":"BFaps2017191_CR6","doi-asserted-by":"publisher","first-page":"325","DOI":"10.1023\/A:1008929526011","volume":"10","author":"DJ Lunn","year":"2000","unstructured":"Lunn DJ, Thomas A, Best N, Spiegelhalter D . Win BUGS\u2013A Bayesian modelling framework: concepts, structure, and extensibility. Statistic Comput 2000; 10: 325\u201337.","journal-title":"Statistic Comput"},{"key":"BFaps2017191_CR7","unstructured":"Sch\u00fcnemann H, Brozek J, Oxman A . GRADE handbook for grading quality of evidence and strength of recommendation.. The GRADE Working Group 2009; Available from: \n                    http:\/\/www.cc-ims.net\/gradepro\n                    \n                  ."},{"key":"BFaps2017191_CR8","first-page":"14","volume":"30","author":"YR Bao","year":"2008","unstructured":"Bao YR . Clinical observation on treating coronary heart disease with Danhong injection. J Inner Mongolia Med Univ 2008; 30: 14\u20135.","journal-title":"J Inner Mongolia Med Univ"},{"key":"BFaps2017191_CR9","first-page":"103","volume":"2","author":"XF Cao","year":"2013","unstructured":"Cao XF, Liu CR . Danhong injection on the inflammatory index of blood lipid and endothelial function in patients with coronary heart disease and angina pectoris. China Rural Health 2013; 2: 103.","journal-title":"China Rural Health"},{"key":"BFaps2017191_CR10","first-page":"137","volume":"27","author":"H Dai","year":"2009","unstructured":"Dai H, Zhang YL, Dai Q . Observation on the effects of Danhong injection in treating 112 cases of angina pectoris. Health Vocat Edu 2009; 27: 137\u20138.","journal-title":"Health Vocat Edu"},{"key":"BFaps2017191_CR11","first-page":"143","volume":"6","author":"HY Diao","year":"2011","unstructured":"Diao HY, Song CL . Observation on the efficacy of Danhong injection in the treatment of coronary heart disease, angina pectoris and myocardial ischemia. China Pract Med 2011; 6: 143\u20134.","journal-title":"China Pract Med"},{"key":"BFaps2017191_CR12","first-page":"65","volume":"12","author":"Q Fan","year":"2011","unstructured":"Fan Q . Observation on the efficacy of Danhong injection and Danshen (Salvia miltiorrhiza) injection in treating coronary heart disease with angina pectoris. Med Front 2011; 12: 65\u20136.","journal-title":"Med Front"},{"key":"BFaps2017191_CR13","first-page":"178","volume":"9","author":"W Gan","year":"2012","unstructured":"Gan W, Li GW . Observation on the efficacy of Danhong injection and Danshen (Salvia miltiorrhiza) injection in treating coronary heart disease with angina pectoris. World Health Dig 2012; 9: 178.","journal-title":"World Health Dig"},{"key":"BFaps2017191_CR14","first-page":"360","volume":"8","author":"LL Han","year":"2014","unstructured":"Han LL . Comparison of the effects of Danhong injection and Danshen (Salvia miltiorrhiza) injection in 58 cases of coronary heart disease. Long Life 2014; 8: 360\u20131.","journal-title":"Long Life"},{"key":"BFaps2017191_CR15","first-page":"4834","volume":"9","author":"AG He","year":"2009","unstructured":"He AG, Wang DX, Cao YH . Observation on the curative effect of Danhong injection in treating coronary heart disease with angina pectoris. Chin J Misdiagnos 2009; 9: 4834\u20135.","journal-title":"Chin J Misdiagnos"},{"key":"BFaps2017191_CR16","first-page":"32","volume":"12","author":"JH Huang","year":"2012","unstructured":"Huang JH . Clinical analysis of Danhong and Tanshinone II in the treatment of coronary heart disease with angina pectoris. Cardiovasc Dis Prev Con Knowledge 2012; 12: 32\u20133.","journal-title":"Cardiovasc Dis Prev Con Knowledge"},{"key":"BFaps2017191_CR17","first-page":"191","volume":"22","author":"YX Huo","year":"2012","unstructured":"Huo YX . Clinical observation on treating angina pectoris of coronary heart disease with Danhong injection. Med Frontier 2012; 22: 191.","journal-title":"Med Frontier"},{"key":"BFaps2017191_CR18","first-page":"687","volume":"11","author":"SP Ji","year":"2013","unstructured":"Ji SP . Therapeutic value of Danhong injection and Danshen (Salvia miltiorrhiza) injection in treating coronary heart disease. Guide China Med 2013; 11: 687\u20138.","journal-title":"Guide China Med"},{"key":"BFaps2017191_CR19","first-page":"93","volume":"12","author":"M Li","year":"2012","unstructured":"Li M, Li XK . Clinical observation on 68 cases of coronary heart disease treated with Danhong injection. Health Horizon 2012; 12: 93.","journal-title":"Health Horizon"},{"key":"BFaps2017191_CR20","first-page":"619","volume":"20","author":"X Li","year":"2010","unstructured":"Li X, Yi T . Clinical effect of Salvianolate injection on patients with coronary heart diseases. China J Modern Med 2010; 20: 619\u201321.","journal-title":"China J Modern Med"},{"key":"BFaps2017191_CR21","first-page":"199","volume":"13","author":"TC Lin","year":"2014","unstructured":"Lin TC, Mao YY . Cost-effectiveness analysis of three Salvia miltiorrhiza preparations in treating angina pectoris of coronary heart disease. World Latest Med 2014; 13: 199\u2013200.","journal-title":"World Latest Med"},{"key":"BFaps2017191_CR22","first-page":"983","volume":"19","author":"DQ Liu","year":"2013","unstructured":"Liu DQ, Zhang SY . Comparative analysis of clinical efficacy of Danhong Injection and Danshen Injection on the treatment of coronary heart disease. Hebei Med 2013; 19: 983\u20135.","journal-title":"Hebei Med"},{"key":"BFaps2017191_CR23","first-page":"1715","volume":"8","author":"JH Liu","year":"2006","unstructured":"Liu JH, Mo GH, Tang L . Clinical study on the blood-stasis syndrome in angina pectoris of coronary heart disease treated with Danhong injection. J Chin Physician 2006; 8: 1715\u20131716, 19.","journal-title":"J Chin Physician"},{"key":"BFaps2017191_CR24","first-page":"80","volume":"7","author":"YQ Liu","year":"2010","unstructured":"Liu YQ . Clinical study on the angina pectoris of coronary heart disease treated with Danhong injection. Med Innovat China 2010; 7: 80\u20131.","journal-title":"Med Innovat China"},{"key":"BFaps2017191_CR25","first-page":"2382","volume":"10","author":"GP Lu","year":"2010","unstructured":"Lu GP . Curative effect analysis of Danhong injection in treatment of coronary heart disease. Chin J Misdiagnostics 2010; 10: 2382\u20133.","journal-title":"Chin J Misdiagnostics"},{"key":"BFaps2017191_CR26","first-page":"17","volume":"23","author":"HM Luo","year":"2007","unstructured":"Luo HM, Lu HD, Yu SC, Yang Y . The final report on the clinical verification of Danhong injection treatment for angina pectoris of coronary heart disease. Chin Community Doctors 2007; 23: 17.","journal-title":"Chin Community Doctors"},{"key":"BFaps2017191_CR27","first-page":"4572","volume":"2","author":"J Peng","year":"2013","unstructured":"Peng J . Efficacy of Danhong injection in treating myocardial ischemia in angina pectoris of coronary heart disease. China Health Care Nutr 2013; 2: 4572\u20133.","journal-title":"China Health Care Nutr"},{"key":"BFaps2017191_CR28","first-page":"93","volume":"5","author":"YH Qi","year":"2008","unstructured":"Qi YH, Song LQ, Zhang ML . Efficacy of Danhong injection in treating myocardial ischemia after acute myocardial infarction. China Med Herald 2008; 5: 93.","journal-title":"China Med Herald"},{"key":"BFaps2017191_CR29","first-page":"338","volume":"19","author":"QP Tan","year":"2013","unstructured":"Tan QP, Liang LC, Liang MJ, Chen WQ . Study on the mechanism of Salvianolate on patients with stable angina pectoris. South China J Cardiovasc Dis 2013; 19: 338\u201340.","journal-title":"South China J Cardiovasc Dis"},{"key":"BFaps2017191_CR30","first-page":"86","volume":"15","author":"H Tang","year":"2014","unstructured":"Tang H . Evaluation of the efficacy of Salvianolate injection in treating angina pectoris of coronary heart disease. Chin Health Standard Management 2014; 15: 86\u20138.","journal-title":"Chin Health Standard Management"},{"key":"BFaps2017191_CR31","first-page":"187","volume":"35","author":"CJ Wang","year":"2013","unstructured":"Wang CJ, Xue QX . Observation on the curative effect of Danhong injection and Danshen (Salvia miltiorrhiza) injection in treating coronary heart disease. J Guiyang Coll Tradit Chin Med 2013; 35: 187\u20138.","journal-title":"J Guiyang Coll Tradit Chin Med"},{"key":"BFaps2017191_CR32","first-page":"33","volume":"29","author":"JX Wang","year":"2008","unstructured":"Wang JX, Li T . Observation on the curative effect of Danhong injection in treating angina pectoris of coronary heart disease. Yunnan J Tradit Chin Med Mater Med 2008; 29: 33.","journal-title":"Yunnan J Tradit Chin Med Mater Med"},{"key":"BFaps2017191_CR33","first-page":"88","volume":"26","author":"K Wang","year":"2013","unstructured":"Wang K, Lin W . Comparison of the efficacy of Danhong and Tanshinone IIA in treating angina pectoris of coronary heart disease. Western J Tradit Chin Med 2013; 26: 88\u20139.","journal-title":"Western J Tradit Chin Med"},{"key":"BFaps2017191_CR34","first-page":"191","volume":"5","author":"W Wang","year":"2011","unstructured":"Wang W . Clinical observation on Danhong injection in treating coronary heart disease. J Liaoning Univ Tradit Chin Med 2011; 5: 191\u20132.","journal-title":"J Liaoning Univ Tradit Chin Med"},{"key":"BFaps2017191_CR35","first-page":"62","volume":"3","author":"YQ Wang","year":"2008","unstructured":"Wang YQ . Clinical observation on the effects of Danhong injection in treating coronary heart disease . China Pract Med 2008; 3: 62\u20133.","journal-title":"China Pract Med"},{"key":"BFaps2017191_CR36","first-page":"189","volume":"14","author":"SX Xin","year":"2012","unstructured":"Xin SX, Li T . Clinical observation on the effect of Danhong injection in treating 86 cases of angina pectoris of coronary heart disease. J Hebei Unit Univ 2012; 14: 189\u201390.","journal-title":"J Hebei Unit Univ"},{"key":"BFaps2017191_CR37","first-page":"179","volume":"7","author":"BP Xu","year":"2012","unstructured":"Xu BP . Clinical analysis of the effect of Danhong injection in treating 126 cases of coronary heart disease with angina pectoris. China Pract Med 2012; 7: 179\u201380.","journal-title":"China Pract Med"},{"key":"BFaps2017191_CR38","first-page":"55","volume":"12","author":"P Yan","year":"2004","unstructured":"Yan P, Luo XP, Shi HM . Clinical effect of Danshen (Salvia miltiorrhiza) polyphenolic acid on patients with angina pectoris and its impact on platelet function. J Intervention Radiol 2004; 12: 55\u20138.","journal-title":"J Intervention Radiol"},{"key":"BFaps2017191_CR39","first-page":"465","volume":"20","author":"QD Yang","year":"2012","unstructured":"Yang QD . Clinical observation on the effect of Danhong injection in treating angina pectoris of coronary heart disease. Pract J Cardiac Cereb Pneum Vasc Dis 2012; 20: 465.","journal-title":"Pract J Cardiac Cereb Pneum Vasc Dis"},{"key":"BFaps2017191_CR40","first-page":"20","volume":"20","author":"H Yang","year":"2009","unstructured":"Yang H, Huang SY . Clinical observation on the effects of Danhong and compound Danshen injections in the treatment of stable angina. J Bingtuan Med 2009; 20: 20\u20131.","journal-title":"J Bingtuan Med"},{"key":"BFaps2017191_CR41","first-page":"1033","volume":"22","author":"WB Yang","year":"2011","unstructured":"Yang WB . Cost-effectiveness analysis of three types of Danshen (Salvia miltiorrhiza) preparations in treating coronary heart disease with angina pectoris. China Pharm 2011; 22: 1033\u20134.","journal-title":"China Pharm"},{"key":"BFaps2017191_CR42","first-page":"15","volume":"30","author":"SM Di","year":"2008","unstructured":"Di SM, Yang XL . Observation on the effect of sodium tanshinone IIA sulfonate (STS) in treating coronary heart disease with angina pectoris. J Inner Mongolia Med Coll 2008; 30: 15\u20136.","journal-title":"J Inner Mongolia Med Coll"},{"key":"BFaps2017191_CR43","first-page":"45","volume":"21","author":"JH Zhan","year":"2014","unstructured":"Zhan JH . Observation on the effect of Danhong injection in the treatment of angina pectoris. Chin Pract J Rural Doctor 2014; 21: 45\u20136.","journal-title":"Chin Pract J Rural Doctor"},{"key":"BFaps2017191_CR44","first-page":"476","volume":"54","author":"H Zhang","year":"2011","unstructured":"Zhang H . Observation on the effect of Danhong injection in the treatment of stable angina of coronary heart disease. People Milit Surg 2011; 54: 476\u20137.","journal-title":"People Milit Surg"},{"key":"BFaps2017191_CR45","first-page":"1208","volume":"36","author":"J Zhang","year":"2008","unstructured":"Zhang J, Sun P . Clinical observation on the effect of Danhong injection in the treatment of angina pectoris of coronary heart disease. Liaoning J Tradit Chin Med 2008; 36: 1208.","journal-title":"Liaoning J Tradit Chin Med"},{"key":"BFaps2017191_CR46","first-page":"170","volume":"5","author":"WG Zhang","year":"2010","unstructured":"Zhang WG . Observation on the effects of Danhong and Danshen injections in the treatment of coronary heart disease. China Pract Med 2010; 5: 170\u20131.","journal-title":"China Pract Med"},{"key":"BFaps2017191_CR47","first-page":"70","volume":"5","author":"YQ Zhang","year":"2012","unstructured":"Zhang YQ . Clinical observation on the effect of Salvianolate injection in the treatment of 68 cases of angina pectoris of coronary heart disease. Chin J Clin Ration Drug Use 2012; 5: 70\u20131.","journal-title":"Chin J Clin Ration Drug Use"},{"key":"BFaps2017191_CR48","first-page":"1039","volume":"4","author":"JW Zheng","year":"2006","unstructured":"Zheng JW . Salvianolate injection in the treatment of 45 cases of coronary heart disease. Chin J Integr Med Cardio-Cerebrovasc Dis 2006; 4: 1039\u201340.","journal-title":"Chin J Integr Med Cardio-Cerebrovasc Dis"},{"key":"BFaps2017191_CR49","first-page":"711","volume":"9","author":"Y Zhou","year":"2007","unstructured":"Zhou Y, Zhou L . Observation on the effect of Danhong injection in the treatment of 150 cases of stable angina. J Chin Physician 2007; 9: 711.","journal-title":"J Chin Physician"},{"key":"BFaps2017191_CR50","first-page":"84","volume":"3","author":"YF Zhou","year":"2008","unstructured":"Zhou YF . Clinical analysis of 85 cases of angina pectoris treated with Danhong injection. China Pract Med 2008; 3: 84.","journal-title":"China Pract Med"},{"key":"BFaps2017191_CR51","first-page":"1291","volume":"29","author":"YH Zhuang","year":"2008","unstructured":"Zhuang YH . Clinical observation on the effects of Danhong injection in treating coronary heart disease. Jilin Med J 2008; 29: 1291\u20132.","journal-title":"Jilin Med J"},{"key":"BFaps2017191_CR52","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1093\/bib\/bbv112","volume":"18","author":"YY Zhang","year":"2017","unstructured":"Zhang YY, Wang Z, Wang Y . Multi-hierarchical profiling: an emerging and quantitative approach to characterizing diverse biological networks. Briefing Bioinform 2017; 18: 57\u201368.","journal-title":"Briefing Bioinform"},{"key":"BFaps2017191_CR53","doi-asserted-by":"publisher","first-page":"2213","DOI":"10.3892\/mmr.2016.5478","volume":"14","author":"Z Zhao","year":"2016","unstructured":"Zhao Z, Zhang Y, Gai F, Wang Y . Confirming an integrated pathology of diabetes and its complications by molecular biomarker-target network analysis. Mol Med Rep 2016; 14: 2213\u201321.","journal-title":"Mol Med Rep"},{"key":"BFaps2017191_CR54","doi-asserted-by":"publisher","first-page":"253","DOI":"10.1111\/cns.12205","volume":"20","author":"YY Zhang","year":"2014","unstructured":"Zhang YY, Li HX, Chen YY, Fang H, Yu YN, Liu J, et al. Convergent and divergent pathways decoding hierarchical additive mechanisms in treating cerebral ischemia\u2013reperfusion Injury. CNS Neurosci Ther 2014; 20: 253\u201363.","journal-title":"CNS Neurosci Ther"},{"key":"BFaps2017191_CR55","first-page":"1","volume":"698531","author":"Y Wang","year":"2012","unstructured":"Wang Y, Liu Z, Li C, Li D, Ouyang Y, Yu J, et al. Drug target prediction based on the herbs components: the study on the multitargets pharmacological mechanism of qishenkeli acting on the coronary heart disease. Evid Based Complement Alternat Med 2012; 698531: 1\u201310.","journal-title":"Evid Based Complement Alternat Med"},{"key":"BFaps2017191_CR56","doi-asserted-by":"publisher","first-page":"128","DOI":"10.1111\/andr.12141","volume":"4","author":"LH Wang","year":"2016","unstructured":"Wang LH, Liu CK, Chen CH, Kao LT, Lin HC, Huang CY . No increased risk of coronary heart disease for patients receiving androgen deprivation therapy for prostate cancer in Chinese\/Taiwanese men. Andrology 2016; 4: 128\u201332.","journal-title":"Andrology"},{"key":"BFaps2017191_CR57","first-page":"19","volume":"40","author":"L Gao","year":"2013","unstructured":"Gao L, Gao D . A study of the correlation between CFHY402H and coronary heart disease. Int J Cardiovasc Dis 2013; 40: 19\u201321.","journal-title":"Int J Cardiovasc Dis"},{"key":"BFaps2017191_CR58","first-page":"3365","volume":"37","author":"T Xu","year":"2015","unstructured":"Xu T, Zhang Z, Wang JP, Tian FY, Liu X . The effect of sodium tanshinone IIA sulfonate combined with atorvastatin on TLR4 inflammatory signaling pathway and immune related indexes in patients with coronary heart disease. Hebei Med J 2015; 37: 3365\u20138.","journal-title":"Hebei Med J"},{"key":"BFaps2017191_CR59","first-page":"396","volume":"8","author":"CW Xu","year":"2016","unstructured":"Xu CW, Jiang XJ, Li DF, Chen J, Yang HD . Meta-analysis of the cohort study of the correlation between asthma and the risk of coronary heart disease. Chin J Evid Based Cardiovasc Med 2016; 8: 396\u2013402.","journal-title":"Chin J Evid Based Cardiovasc Med"},{"key":"BFaps2017191_CR60","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1016\/j.healun.2016.07.016","volume":"36","author":"C Lu","year":"2017","unstructured":"Lu C, Zeng YQ, Liu H, Xie Q, Xu S, Tu K, et al. Tanshinol suppresses cardiac allograft rejection in a murine model. J Heart Lung Transplant 2017; 36: 227\u201336.","journal-title":"J Heart Lung Transplant"},{"key":"BFaps2017191_CR61","first-page":"811","volume":"29","author":"DP Ying","year":"2009","unstructured":"Ying DP, Xu B . The levels of peripheral CD4+Foxp3+ regulatory T cells and cytokines in patients with coronary heart disease and their clinical significance. Acta Univ Med Nanjing 2009; 29: 811\u20134.","journal-title":"Acta Univ Med Nanjing"},{"key":"BFaps2017191_CR62","first-page":"386","volume":"24","author":"H Zheng","year":"2004","unstructured":"Zheng H, Wu SZ, Lai WY . Comparative study of T cell proliferation response in different types of coronary heart disease. J First Milit Med Univ 2004; 24: 386\u20138.","journal-title":"J First Milit Med Univ"},{"key":"BFaps2017191_CR63","first-page":"2538","volume":"39","author":"Y Liang","year":"2014","unstructured":"Liang Y, Chen Y, Yan JC . The levels of activated T cells, helper T cell subsets and CXCR3 expression in patients with coronary heart disease. Jiangsu Med J 2014; 39: 2538\u201340.","journal-title":"Jiangsu Med J"},{"key":"BFaps2017191_CR64","doi-asserted-by":"publisher","first-page":"744","DOI":"10.1016\/S1053-2498(98)00039-4","volume":"18","author":"H Song","year":"1999","unstructured":"Song H . Conte JV Jr, Foster AH, McLaughlin JS, Wei C . Increased p53 protein expression in human failing myocardium. J Heart Lung Transplant 1999; 18: 744\u20139.","journal-title":"J Heart Lung Transplant"},{"key":"BFaps2017191_CR65","first-page":"25","volume":"65","author":"S Ikeda","year":"1999","unstructured":"Ikeda S, Hamada M, Hiwada K . Cardiomyocyte apoptosis with enhanced expression of p53 and Bax in right ventricle after pulmonary arterial banding. Life Sci 1999; 65: 25\u201333.","journal-title":"Life Sci"},{"key":"BFaps2017191_CR66","first-page":"60","volume":"7","author":"JG Jiang","year":"2001","unstructured":"Jiang JG . The relationship between apoptosis and myocardial ischemia reperfusion injury. Med Recap 2001; 7: 60\u20137.","journal-title":"Med Recap"},{"key":"BFaps2017191_CR67","first-page":"2804","volume":"36","author":"J Yao","year":"2010","unstructured":"Yao J, Cao S, Shen SR . The effect of diazoxide on p53 expression in hypoxia-reoxygenated cardiac microvascular endothelial cells. Jiangsu Med J 2010; 36: 2804\u20136.","journal-title":"Jiangsu Med J"}],"container-title":["Acta Pharmacologica Sinica"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nature.com\/articles\/aps2017191.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/aps2017191","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/doifinder\/10.1038\/aps.2017.191","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"http:\/\/www.nature.com\/articles\/aps2017191.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,18]],"date-time":"2023-05-18T12:36:07Z","timestamp":1684413367000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/aps2017191"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,2,8]]},"references-count":67,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2018,6]]}},"alternative-id":["BFaps2017191"],"URL":"https:\/\/doi.org\/10.1038\/aps.2017.191","relation":{},"ISSN":["1671-4083","1745-7254"],"issn-type":[{"value":"1671-4083","type":"print"},{"value":"1745-7254","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,2,8]]},"assertion":[{"value":"17 June 2017","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 November 2017","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 February 2018","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}]}}